Works matching IS 08876924 AND DT 2011 AND VI 25 AND IP 1

Results: 27

Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 153, doi. 10.1038/leu.2010.245

By:

Burkhardt, B.;
Oschlies, I.;
Klapper, W.;
Zimmermann, M.;
Woessmann, W.;
Meinhardt, A.;
Landmann, E.;
Attarbaschi, A.;
Niggli, F.;
Schrappe, M.;
Reiter, A.

Publication type:

Article

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 32, doi. 10.1038/leu.2010.222

By:

Lin, T.-C.;
Hou, H.-A.;
Chou, W.-C.;
Ou, D.-L.;
Yu, S.-L.;
Tien, H.-F.;
Lin, L.-.I

Publication type:

Article

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 89, doi. 10.1038/leu.2010.233

By:

Kruse, U.;
Pallasch, C. P.;
Bantscheff, M.;
Eberhard, D.;
Frenzel, L.;
Ghidelli, S.;
Maier, S. K.;
Werner, T.;
Wendtner, C. M.;
Drewes, G.

Publication type:

Article

Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 48, doi. 10.1038/leu.2010.246

By:

Ta, V. B. T.;
de Haan, A. B.;
de Bruijn, M. J. W.;
Dingjan, G. M.;
Hendriks, R. W.

Publication type:

Article

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia.

Published in:

2011

By:

Handgretinger, R.;
Zugmaier, G.;
Henze, G.;
Kreyenberg, H.;
Lang, P.;
von Stackelberg, A.

Publication type:

Letter

Reduced methyl-CpG protein binding contributing to miR-184 expression in umbilical cord blood CD4+ T-cells.

Published in:

2011

By:

Weitzel, R. P.;
Lesniewski, M. L.;
Greco, N. J.;
Laughlin, M. J.

Publication type:

Letter

Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 57, doi. 10.1038/leu.2010.251

By:

Nicolas, E.;
Ramus, C.;
Berthier, S.;
Arlotto, M.;
Bouamrani, A.;
Lefebvre, C.;
Morel, F.;
Garin, J.;
Ifrah, N.;
Berger, F.;
Cahn, J. Y.;
Mossuz, P.

Publication type:

Article

A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders.

Published in:

2011

By:

Yoshida, K.;
Sanada, M.;
Kato, M.;
Kawahata, R.;
Matsubara, A.;
Takita, J.;
Shih, L.-Y.;
Mori, H.;
Koeffler, H. P.;
Ogawa, S.

Publication type:

Letter

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 75, doi. 10.1038/leu.2010.219

By:

Robin, M.;
Sanz, G. F.;
Ionescu, I.;
Rio, B.;
Sirvent, A.;
Renaud, M.;
Carreras, E.;
Milpied, N.;
Mohty, M.;
Beguin, Y.;
Bordigoni, P.;
de Witte, T.;
Picardi, A.;
Purtill, D.;
Gluckman, E.;
Kroger, N.;
Rocha, V.

Publication type:

Article

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.

Published in:

2011

By:

Soverini, S.;
Score, J.;
Iacobucci, I.;
Poerio, A.;
Lonetti, A.;
Gnani, A.;
Colarossi, S.;
Ferrari, A.;
Castagnetti, F.;
Rosti, G.;
Cervantes, F.;
Hochhaus, A.;
Delledonne, M.;
Ferrarini, A.;
Sazzini, M.;
Luiselli, D.;
Baccarani, M.;
Cross, N. C. P.;
Martinelli, G.

Publication type:

Case Study

Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 121, doi. 10.1038/leu.2010.235

By:

Federmann, B.;
Hägele, M.;
Pfeiffer, M.;
Wirths, S.;
Schumm, M.;
Faul, C.;
Vogel, W.;
Handgretinger, R.;
Kanz, L.;
Bethge, W. A.

Publication type:

Article

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 41, doi. 10.1038/leu.2010.228

By:

Mizuta, S.;
Matsuo, K.;
Yagasaki, F.;
Yujiri, T.;
Hatta, Y.;
Kimura, Y.;
Ueda, Y.;
Kanamori, H.;
Usui, N.;
Akiyama, H.;
Miyazaki, Y.;
Ohtake, S.;
Atsuta, Y.;
Sakamaki, H.;
Kawa, K.;
Morishima, Y.;
Ohnishi, K.;
Naoe, T.;
Ohno, R.

Publication type:

Article

Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 101, doi. 10.1038/leu.2010.240

By:

Le Garff-Tavernier, M.;
Decocq, J.;
de Romeuf, C.;
Parizot, C.;
Dutertre, C. A.;
Chapiro, E.;
Davi, F.;
Debré, P.;
Prost, J. F.;
Teillaud, J. L.;
Merle-Beral, H.;
Vieillard, V.

Publication type:

Article

The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.

Published in:

2011

By:

Benedikt, A.;
Baltruschat, S.;
Scholz, B.;
Bursen, A.;
Arrey, T. N.;
Meyer, B.;
Varagnolo, L.;
Müller, A. M.;
Karas, M.;
Dingermann, T.;
Marschalek, R.;
Müller, A M

Publication type:

journal article

Low prevalence of IDH1 gene mutation in childhood AML in Italy.

Published in:

2011

By:

Pigazzi, M.;
Ferrari, G.;
Masetti, R.;
Falini, B.;
Martinolli, F.;
Basso, G.;
Biondi, A.;
Pession, A.;
Cazzaniga, G.

Publication type:

Letter

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells.

Published in:

2011

By:

Song, W.;
Tai, Y.-T;
Tian, Z.;
Hideshima, T.;
Chauhan, D.;
Nanjappa, P.;
Exley, M. A.;
Anderson, K. C.;
Munshi, N. C.

Publication type:

journal article

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.

Published in:

2011

By:

Mallo, M.;
Cervera, J.;
Schanz, J.;
Such, E.;
García-Manero, G.;
Luño, E.;
Steidl, C.;
Espinet, B.;
Vallespí, T.;
Germing, U.;
Blum, S.;
Ohyashiki, K.;
Grau, J.;
Pfeilstöcker, M.;
Hernández, J. M.;
Noesslinger, T.;
Giagounidis, A.;
Aul, C.;
Calasanz, M. J.;
Martín, M. L.

Publication type:

journal article

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.

Published in:

2011

By:

Lin, J;
Lwin, T;
Zhao, J-J;
Tam, W;
Choi, Y S;
Moscinski, L C;
Dalton, W S;
Sotomayor, E M;
Wright, K L;
Tao, J

Publication type:

journal article

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 23, doi. 10.1038/leu.2010.225

By:

Liu, L.;
Yang, M.;
Kang, R.;
Wang, Z.;
Zhao, Y.;
Yu, Y.;
Xie, M.;
Yin, X.;
Livesey, K. M.;
Lotze, M. T.;
Tang, D.;
Cao, L.

Publication type:

Article

Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients.

Published in:

2011

By:

Bardini, M.;
Galbiati, M.;
Lettieri, A.;
Bungaro, S.;
Gorletta, T. A.;
Biondi, A.;
Cazzaniga, G.

Publication type:

Letter

A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.

Published in:

2011

By:

Chen, S.-H.;
Yang, W.;
Fan, Y.;
Stocco, G.;
Crews, K. R.;
Yang, J. J.;
Paugh, S. W.;
Pui, C.-H.;
Evans, W. E.;
Relling, M. V.

Publication type:

journal article

The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation.

Published in:

2011

By:

Mohty, M.;
Duarte, R. F.;
Croockewit, S.;
Hübel, K.;
Kvalheim, G.;
Russell, N.;
Hübel, K

Publication type:

Editorial

Inactivating GGTase-I reduces disease phenotypes in a mouse model of K-RAS-induced myeloproliferative disease.

Published in:

2011

By:

Sjogren, A.-K. M.;
Andersson, K. M. E.;
Khan, O.;
Olofsson, F. J.;
Karlsson, C.;
Bergo, M. O.

Publication type:

Letter

TET2 mutations in childhood leukemia.

Published in:

2011

By:

Langemeijer, S. M. C.;
Jansen, J. H.;
Hooijer, J.;
van Hoogen, P.;
Stevens-Linders, E.;
Massop, M.;
Waanders, E.;
van Reijmersdal, S. V.;
Stevens-Kroef, M. J. P. L.;
Zwaan, C. M.;
van den Heuvel-Eibrink, M. M.;
Sonneveld, E.;
Hoogerbrugge, P. M.;
Geurts van Kessel, A.;
Kuiper, R. P.;
van Kessel, A Geurts

Publication type:

Letter

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.

Published in:

2011

By:

Caramazza, D.;
Begna, K. H.;
Gangat, N.;
Vaidya, R.;
Siragusa, S.;
Van Dyke, D. L.;
Hanson, C.;
Pardanani, A.;
Tefferi, A.

Publication type:

journal article

Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia.

Published in:

Leukemia (08876924), 2011, v. 25, n. 1, p. 7, doi. 10.1038/leu.2010.238

By:

Bixby, D.;
Talpaz, M.

Publication type:

Article

PHF6 mutations in adult acute myeloid leukemia.

Published in:

2011

By:

Van Vlierberghe, P.;
Patel, J.;
Abdel-Wahab, O.;
Lobry, C.;
Hedvat, C. V.;
Balbin, M.;
Nicolas, C.;
Payer, A. R.;
Fernandez, H. F.;
Tallman, M. S.;
Paietta, E.;
Melnick, A.;
Vandenberghe, P.;
Speleman, F.;
Aifantis, I.;
Cools, J.;
Levine, R.;
Ferrando, A.

Publication type:

journal article

Works matching IS 08876924 AND DT 2011 AND VI 25 AND IP 1

Non-Hodgkin's lymphoma in adolescents: experiences in 378 adolescent NHL patients treated according to pediatric NHL-BFM protocols.

CEBPA methylation as a prognostic biomarker in patients with de novo acute myeloid leukemia.

Chemoproteomics-based kinome profiling and target deconvolution of clinical multi-kinase inhibitors in primary chronic lymphocytic leukemia cells.

Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.

Complete remission after blinatumomab-induced donor T-cell activation in three pediatric patients with post-transplant relapsed acute lymphoblastic leukemia.

Reduced methyl-CpG protein binding contributing to miR-184 expression in umbilical cord blood CD4<sup>+</sup> T-cells.

Expression of S100A8 in leukemic cells predicts poor survival in de novo AML patients.

A nonsense mutation of IDH1 in myelodysplastic syndromes and related disorders.

Unrelated cord blood transplantation in adults with myelodysplasia or secondary acute myeloblastic leukemia: a survey on behalf of Eurocord and CLWP of EBMT.

IDH2 somatic mutations in chronic myeloid leukemia patients in blast crisis.

Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts.

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia.

Analysis of CD16<sup>+</sup>CD56<sup>dim</sup> NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies.

The leukemogenic AF4-MLL fusion protein causes P-TEFb kinase activation and altered epigenetic signatures.

Low prevalence of IDH1 gene mutation in childhood AML in Italy.

HDAC inhibition by LBH589 affects the phenotype and function of human myeloid dendritic cells.

Impact of adjunct cytogenetic abnormalities for prognostic stratification in patients with myelodysplastic syndrome and deletion 5q.

Follicular dendritic cell-induced microRNA-mediated upregulation of PRDM1 and downregulation of BCL-6 in non-Hodgkin's B-cell lymphomas.

HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells.

Implementation of array based whole-genome high-resolution technologies confirms the absence of secondary copy-number alterations in MLL-AF4-positive infant ALL patients.

A genome-wide approach identifies that the aspartate metabolism pathway contributes to asparaginase sensitivity.

The role of plerixafor in optimizing peripheral blood stem cell mobilization for autologous stem cell transplantation.

Inactivating GGTase-I reduces disease phenotypes in a mouse model of K-RAS-induced myeloproliferative disease.

TET2 mutations in childhood leukemia.

Refined cytogenetic-risk categorization for overall and leukemia-free survival in primary myelofibrosis: a single center study of 433 patients.

Seeking the causes and solutions to imatinib-resistance in chronic myeloid leukemia.

PHF6 mutations in adult acute myeloid leukemia.